abstract |
The present invention relates to novel renin inhibitors of general formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also relates to related embodiments, including methods for preparing the compounds. This novel renin inhibitor is used in the treatment of cardiovascular events and renal failure. |